Package 60215-411-30

Brand: fludeoxyglucose f18

Generic: fludeoxyglucose f18
NDC Package

Package Facts

Identity

Package NDC 60215-411-30
Digits Only 6021541130
Product NDC 60215-411
Product ID 60215-411_4041af0a-011f-ddc6-e063-6394a90af478
Description

27 mL in 1 VIAL, GLASS (60215-411-30)

Marketing

Marketing Status
Marketed Since 2011-12-06
Brand fludeoxyglucose f18
Generic fludeoxyglucose f18
Sample Package No

Linked Drug Pages (1)

Fludeoxyglucose F18 ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "4041af0a-011f-ddc6-e063-6394a90af478", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["43954e40-bb95-4275-92ab-96211b7de907"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["The University of Texas MD Anderson Cancer Center"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "27 mL in 1 VIAL, GLASS (60215-411-30)", "package_ndc": "60215-411-30", "marketing_start_date": "20111206"}], "brand_name": "Fludeoxyglucose F18", "product_id": "60215-411_4041af0a-011f-ddc6-e063-6394a90af478", "dosage_form": "INJECTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "60215-411", "generic_name": "Fludeoxyglucose F18", "labeler_name": "The University of Texas MD Anderson Cancer Center", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fludeoxyglucose", "brand_name_suffix": "F18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": "300 mCi/mL"}], "application_number": "ANDA203246", "marketing_category": "ANDA", "marketing_start_date": "20111206", "listing_expiration_date": "20261231"}